The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Product With Increased Stability Comprising Immunoglobulins - EP3763384

The patent EP3763384 was granted to CSL Behring on Aug 28, 2024. The application was filed on Dec 3, 2015 under application number EP20186174A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3763384

CSL BEHRING
Application Number
EP20186174A
Filing Date
Dec 3, 2015
Status
Granted And Under Opposition
Jul 26, 2024
Publication Date
Aug 28, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
OCTAPHARMAMay 28, 2025ULLRICH & NAUMANN PARTG MBBADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2011104315
DESCRIPTIONWO2012022734
DESCRIPTIONWO2014041307
OPPOSITIONFR2995213
OPPOSITIONUS2008072992
OPPOSITIONUS2015224264
OPPOSITIONWO03039632
OPPOSITIONWO2011104315
OPPOSITIONWO2014140097
SEARCHEP2361636
SEARCHEP3202389
SEARCHFR2995213
SEARCHGB2471726
SEARCHWO03039632
SEARCHWO2012151247
SEARCHWO2014140095
SEARCHWO2014140097

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents